Nan Geng

Nan Geng (), personal name Zi Geng, was a king of the Shang dynasty of ancient China. Provided by Wikipedia
Showing 1 - 6 results of 6 for search 'Nan Geng', query time: 0.12s Refine Results
  1. 1
    Introduction of Collaboration for Environmental Evidence and guidelines and standards for evidence synthesis in environmental management

    Introduction of Collaboration for Environmental Evidence and guidelines and standards for evidence synthesis in environmental management by Jing-Chun FAN, Nan GENG, Zheng-Gang BAI, Ke-Hu YANG, Gui-Sen ZHENG

    Published 2020-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Screening Mutagenic Strains with High Triterpene Content from Sanghuangporus baumii and Studying Their Antioxidant Capacity

    Screening Mutagenic Strains with High Triterpene Content from Sanghuangporus baumii and Studying Their Antioxidant Capacity by YaWei Li, WenQi Xiao, XinYu Tong, NanNan Geng, TingTing Sun, Li Zou

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Dynamic skeletal muscle loss and its predictive role on 90-day mortality in patients with acute-on-chronic liver failure

    Dynamic skeletal muscle loss and its predictive role on 90-day mortality in patients with acute-on-chronic liver failure by Nan Geng, Ming Kong, Jiateng Zhang, Manman Xu, Huina Chen, Huina Chen, Wenyan Song, Yu Chen, Zhongping Duan

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Evaluating the predictive performance of PIRO score against six clinical prediction scores for COVID-19 outcomes in the emergency department

    Evaluating the predictive performance of PIRO score against six clinical prediction scores for COVID-19 outcomes in the emergency department by Nan Geng, Zhipeng Wu, Chunlian Lai, Yingying Cui, Yixin Miao, Mengyun Li, Bojun Wang, Hongbo Shi, Yingmin Ma, Bo Liu

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Crypto assets and CBDCs in Latin America and the Caribbean: Opportunities and risks

    Crypto assets and CBDCs in Latin America and the Caribbean: Opportunities and risks by Olga Bespalova, Maximiliano Appendino, Rina Bhattacharya, Jean Francois Clevy Aguilar, Nan Geng, Takuji Komatsuzaki, Justin Lesniak, Weicheng Lian, Sandra Marcelino, Mauricio Villafuerte, Yorbol Yakhshilikov

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Efficacy and safety of first‐line sintilimab plus anlotinib versus chemotherapy for metastatic non‐small cell lung cancer: a phase II, open‐label, randomized controlled trial

    Efficacy and safety of first‐line sintilimab plus anlotinib versus chemotherapy for metastatic non‐small cell lung cancer: a phase II, open‐label, randomized controlled trial by Tianqing Chu, Hua Zhong, Zhuang Yu, Jing Wang, Yanqiu Zhao, Xiaoqian Mu, Xinmin Yu, Xun Shi, Qingming Shi, Maojing Guan, Cuimin Ding, Nan Geng, Jialin Qian, Baohui Han

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: